Decreased STARD10 expression is associated with defective insulin secretion in humans and mice.
Genetic variants near ARAP1 (CENTD2) and STARD10 influence type 2 diabetes (T2D) risk. The risk alleles impair glucose-induced insulin secretion and, paradoxically but characteristically, are associated with decreased proinsulin:insulin ratios, indicating improved proinsulin conversion. Neither the...
Asıl Yazarlar: | Carrat, G, Hu, M, Nguyen-Tu, M, Chabosseau, P, Gaulton, K, van de Bunt, M, Siddiq, A, Falchi, M, Thurner, M, Canouil, M, Pattou, F, Leclerc, I, Pullen, T, Cane, M, Prabhala, P, Greenwald, W, Schulte, A, Marchetti, P, Ibberson, M, MacDonald, P, Manning Fox, J, Gloyn, A, Froguel, P, Solimena, M, McCarthy, M, Rutter, G |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Elsevier
2017
|
Benzer Materyaller
-
Decreased STARD10 expression is associated with defective insulin secretion in humans and mice
Yazar:: Carrat, G, ve diğerleri
Baskı/Yayın Bilgisi: (2017) -
The type 2 diabetes gene product STARD10 is a phosphoinositide binding protein that controls insulin secretory granule biogenesis
Yazar:: Carrat, GR, ve diğerleri
Baskı/Yayın Bilgisi: (2020) -
Changes in the expression of the type 2 diabetes-associated gene VPS13C in the β cell are associated with glucose intolerance in humans and mice
Yazar:: Mehta, Z, ve diğerleri
Baskı/Yayın Bilgisi: (2016) -
Changes in the expression of the type 2 diabetes-associated gene VPS13C in the β-cell are associated with glucose intolerance in humans and mice.
Yazar:: Mehta, Z, ve diğerleri
Baskı/Yayın Bilgisi: (2016) -
[Diagnostic (STARD) and prognostic (REMARK) studies].
Yazar:: Altman, D, ve diğerleri
Baskı/Yayın Bilgisi: (2005)